Clik here to view.
Looking to crowd-sourcing to improve our understanding of fever
What, exactly, is a fever? It’s a surprisingly simple but important question in medicine. While a body temperature of 98.6°F (37°C) is generally considered “normal,” this number doesn’t account for...
View ArticleClik here to view.
Abbott prevails in 10-year-old stent lawsuit
A 10-year-old whistleblower lawsuit filed by a former Abbott (NYSE:ABT) sales rep, over the alleged off-label marketing of biliary stents, ended yesterday when a Dallas jury found for Abbott. Plaintiff...
View ArticleClik here to view.
AngioDynamics slips after hours on lowered guidance
Share prices slipped after hours yesterday after AngioDynamics (NSDQ:ANGO) lowered its outlook for the rest of fiscal 2016, despite a swing to profits on better-than-expected fiscal 3rd-quarter...
View ArticleClik here to view.
EmboMedics raises $4.3m for embolization microbeads
EmboMedics said it raised a $4.3 million Series A1 round for the bioresorbable embolization microspheres it’s developing. Maple Grove, Minn.-based EmboMedics said it plans to use the proceeds to pursue...
View ArticleClik here to view.
Mach7 Technologies closes $60m merger with 3D Medical
Mach7 Technologies said today that it closed its $60 merger with 3D Medical (ASX:3DM), saying it will begin trading on the Australian Stock Exchange under the “M7T” symbol. The deal unites Mach7’s...
View ArticleClik here to view.
Dehaier gains on 2015 prelims
Share prices for China’s Dehaier Medical Systems (NSDQ:DHRM) jumped today after it released preliminary numbers for last year, despite massive losses incurred as it sheds unprofitable medical device...
View ArticleClik here to view.
Windgap Medical raises $3m for epinephrine auto-injector
Windgap Medical said in a regulatory filing today that it raised a debt-and-options round worth $2.9 million for the epinephrine auto-injector it’s developing. Somerville, Mass.-based Windgap is...
View ArticleClik here to view.
Grifols puts up $100m for a 49% stake in Interstate Blood Bank
Grifols (NSDQ:GRFS) said today that it agreed to pay $100 million for a 49% stake in plasma collector Interstate Blood Bank. The deal includes an option to buy the remaining 51% for another $100...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for April 8, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
MTD Micro Molding expands tooling and molding departments
MTD Micro Molding (www.mtdmicromolding.com), a long-time leader in micro-injection molding for the medical device industry, invests in additional capacity in their in-house tooling and molding...
View ArticleClik here to view.
Medtronic disputes newspaper’s Infuse story
Medtronic (NYSE:MDT) yesterday disputed a newspaper’s report about an internal review of some 3,647 patients implanted with its controversial Infuse bone-growth protein, saying the piece made false...
View ArticleClik here to view.
Boston Scientific recalls Fetch 2 thrombectomy catheters
Boston Scientific (NYSE:BSX) recalled the Fetch 2 aspiration catheter it acquired from Bayer (ETR:BAYN) in 2014, after receiving complaints of shaft breakage during coronary thrombectomy procedures....
View ArticleClik here to view.
St. Jude Medical’s Axium chronic pain device makes its U.S. debut
St. Jude Medical (NYSE:STJ) today announced the U.S. debut of its Axium neurostimulator system, after the device won FDA approval in February for treating chronic pain. The 1st patients were implanted...
View ArticleClik here to view.
CeQur looks to treble workforce in Massachusetts
CeQur is looking to treble the size of its workforce in Massachusetts with an expansion of the plant in Marlborough it plans to use to make the PaQ insulin device it hopes to launch this year. PaQ, a...
View ArticleClik here to view.
Vascular Solutions initiates voluntary recall of Guardian II valve
Vascular Solutions (NSDQ:VASC) said today it initiated a recall of its Guardian II hemostasis valves designed for use in catheterization procedures over an increased risk of air leakage that could lead...
View ArticleClik here to view.
Boston Scientific’s Penang plant slated to open late 2017
Boston Scientific‘s (NYSE:BSX) new medical device manufacturing plant in Batu Kawan Industrial Park in Penang, Malaysia is set to open in the 4th quarter of 2017, according to Malaysia’s StarBiz paper....
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for April 11, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Profound Medical wins CE Mark for Tulsa-Pro ablation device
Profound Medical said today it won CE Mark approval in the European Union for its Tulsa-Pro ablation device designed to treat prostate cancer. The Toronto-based company’s system allows for a minimally...
View ArticleClik here to view.
Profusa wins $1.75m NIH grant for tissue-integrated biosensors
San Francisco-based tissue-integrated sensor maker Profusa said today it won a $1.75 million grant from the National Institutes of Health’s Small Business Innovation Research program. Funding is slated...
View ArticleClik here to view.
FDA clears Nephros after 2015 warning letter
Nephros (OTC:NEPH) said last week it received a notice from the FDA closing out a warning letter the company received last May concerning issues with the manufacturing of a variety of its filtration...
View Article
